19,500 Solventum Corporation $SOLV Shares Acquired by VIRGINIA RETIREMENT SYSTEMS ET Al

VIRGINIA RETIREMENT SYSTEMS ET Al grew its position in Solventum Corporation (NYSE:SOLV) by 147.7% in the 3rd quarter, Holdings Channel.com reports. The fund owned 32,700 shares of the company’s stock after acquiring an additional 19,500 shares during the quarter. VIRGINIA RETIREMENT SYSTEMS ET Al’s holdings in Solventum were worth $2,883,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also modified their holdings of SOLV. Choreo LLC grew its position in Solventum by 2.9% during the 3rd quarter. Choreo LLC now owns 12,910 shares of the company’s stock worth $1,138,000 after purchasing an additional 368 shares during the last quarter. Motley Fool Asset Management LLC increased its stake in Solventum by 43.8% in the third quarter. Motley Fool Asset Management LLC now owns 5,109 shares of the company’s stock valued at $450,000 after purchasing an additional 1,555 shares during the period. North Dakota State Investment Board increased its stake in Solventum by 3.1% in the third quarter. North Dakota State Investment Board now owns 4,525 shares of the company’s stock valued at $399,000 after purchasing an additional 134 shares during the period. Laurel Wealth Advisors LLC purchased a new stake in shares of Solventum in the third quarter valued at about $29,000. Finally, Busey Bank raised its holdings in shares of Solventum by 13.8% in the third quarter. Busey Bank now owns 3,231 shares of the company’s stock valued at $285,000 after buying an additional 393 shares during the last quarter.

Solventum Stock Performance

Shares of SOLV opened at $84.52 on Tuesday. The company has a 50-day simple moving average of $88.02 and a 200-day simple moving average of $78.54. The company has a quick ratio of 0.74, a current ratio of 1.02 and a debt-to-equity ratio of 1.00. The company has a market capitalization of $14.39 billion, a PE ratio of 11.53, a P/E/G ratio of 1.20 and a beta of 0.63. Solventum Corporation has a 52-week low of $62.38 and a 52-week high of $94.16.

Solventum (NYSE:SOLV) last released its quarterly earnings results on Wednesday, August 5th. The company reported $2.55 earnings per share for the quarter, topping analysts’ consensus estimates of $1.91 by $0.64. Solventum had a return on equity of 25.09% and a net margin of 17.26%. The business had revenue of $2.21 billion for the quarter, compared to analysts’ expectations of $2.15 billion. During the same quarter in the prior year, the firm posted $1.69 EPS. The company’s revenue was up 2.2% compared to the same quarter last year. Solventum has set its FY 2026 guidance at 7.100-7.200 EPS. Equities research analysts predict that Solventum Corporation will post 7.20 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts recently issued reports on SOLV shares. Jefferies Financial Group restated a “buy” rating on shares of Solventum in a research report on Thursday, October 8th. Benchmark reaffirmed a “buy” rating on shares of Solventum in a research report on Thursday, October 8th. Mizuho set a $113.00 target price on Solventum in a research note on Thursday, August 6th. UBS Group boosted their target price on Solventum from $95.00 to $101.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Finally, BMO Capital Markets initiated coverage on Solventum in a research note on Wednesday, July 8th. They set a “market perform” rating and a $81.00 price target for the company. Ten investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $87.55.

Solventum Profile

Solventum Corporation (NYSE: SOLV) is a global healthcare company that develops products and solutions intended to improve patient care, support healthcare professionals and enhance the efficiency of healthcare systems. Its offerings serve hospitals, clinics, dental practices, laboratories, manufacturers and other healthcare-related organizations.

The company’s portfolio includes medical and surgical products such as wound-care systems, dressings, skin-protection products, sterilization assurance products and solutions used in operating rooms.